NKARTA INC. - COMMON STOCK

Nkarta to Participate in an April Investor Conference

01 апр 2025 07:01:00 Источник Nasdaq GlobeNewswire

Nkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights

26 мар 2025 15:01:00 Источник Nasdaq GlobeNewswire

Nkarta to Participate in March Investor Conferences

25 фев 2025 07:01:00 Источник Nasdaq GlobeNewswire

Nkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2

05 дек 2024 05:01:00 Источник Nasdaq GlobeNewswire

Nkarta to Participate in an Upcoming Investor Conference

26 ноя 2024 06:02:00 Источник Nasdaq GlobeNewswire

Nkarta to Participate in an Upcoming Investor Conference

12 ноя 2024 07:02:00 Источник Nasdaq GlobeNewswire

Nkarta Reports Third Quarter 2024 Financial Results and Corporate Highlights

07 ноя 2024 15:02:00 Источник Nasdaq GlobeNewswire

Nkarta to Participate in Upcoming Investor Conference

03 сен 2024 15:01:00 Источник Nasdaq GlobeNewswire

Correction: Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights

13 авг 2024 20:03:42 Источник Nasdaq GlobeNewswire

Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights

13 авг 2024 15:01:00 Источник Nasdaq GlobeNewswire

Nkarta Announces Initiation of Investigator-Sponsored Clinical Trial Evaluating NKX019 for Systemic Lupus Erythematosus

24 июл 2024 05:00:00 Источник Nasdaq GlobeNewswire

Nkarta Announces Leadership Updates, Appoints Nadir Mahmood as President

16 июл 2024 05:01:00 Источник Nasdaq GlobeNewswire

Nkarta Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Announces Pipeline Expansion to Additional Autoimmune Indications

27 июн 2024 05:00:00 Источник Nasdaq GlobeNewswire

Nkarta Adds Experienced Leader in Autoimmune R&D, George Vratsanos, M.D., FACR, to Board of Directors

13 июн 2024 15:01:00 Источник Nasdaq GlobeNewswire

Nkarta Reports First Quarter 2024 Financial Results and Corporate Highlights

09 май 2024 15:01:00 Источник Nasdaq GlobeNewswire

Nkarta to Participate in Upcoming Investor Conferences

03 апр 2024 15:02:00 Источник Nasdaq GlobeNewswire

Nkarta Announces Pricing of $240 Million Underwritten Offering

25 мар 2024 05:30:00 Источник Nasdaq GlobeNewswire

Nkarta Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights

21 мар 2024 15:01:00 Источник Nasdaq GlobeNewswire

Nkarta to Participate in Upcoming Investor Conferences

28 фев 2024 07:01:00 Источник Nasdaq GlobeNewswire

Nkarta Presents NKX101 Clinical Data at the 2023 American Society of Hematology Annual Meeting & Exposition

09 дек 2023 19:31:00 Источник Nasdaq GlobeNewswire